Affidea is a leading provider of diagnostic imaging and cancer care services in the Netherlands. Founded in 1993, the company has rapidly expanded over the years and established itself as a trusted name in the healthcare industry. Affidea's headquarters in the Netherlands is located in Utrecht.

It serves as the central hub for the company's operations in the country. The headquarters is responsible for overseeing the management and strategic direction of Affidea's various facilities in the Netherlands. The company offers a wide range of products and services, including MRI scans, CT scans, ultrasounds, X-rays, mammography, and nuclear medicine.

These services are provided through a network of state-of-the-art clinics and hospitals across the Netherlands. On a global scale, Affidea has a strong presence in Europe with a network of over 245 centers across 14 countries. The company employs a team of highly skilled medical professionals and uses advanced equipment to deliver accurate diagnoses and personalized treatment plans to its patients.

Affidea has established several noteworthy partnerships and joint ventures to expand its services and reach. One notable partnership is with the European Oncology Institute (IOE), which aims to enhance cancer care services in Europe through research, training, and innovation. The company has also collaborated with academic institutions and research centers to drive advancements in diagnostic imaging and cancer treatment.

In terms of market position, Affidea is a prominent player in the global healthcare industry. It has a strong customer base and a reputation for delivering high-quality services. The company strives to stay ahead of its competitors by continuously investing in cutting-edge technology and expanding its network of clinics and hospitals.

In recent years, Affidea has undergone significant growth and expansion. The company has made strategic acquisitions and partnerships to strengthen its presence in key markets. It has also introduced innovative services and solutions to meet the evolving needs of patients and healthcare providers.

As of the latest available information, Affidea continues to grow and expand its operations globally. The company remains committed to delivering exceptional patient care and driving advancements in diagnostic imaging and cancer care services